Your browser doesn't support javascript.
loading
B-cell characteristics define HCV reinfection outcome.
Underwood, Alexander P; Gupta, Money; Wu, Bing-Ru; Eltahla, Auda A; Boo, Irene; Wang, Jing Jing; Agapiou, David; Abayasingam, Arunasingam; Reynaldi, Arnold; Keoshkerian, Elizabeth; Zhao, Yanran; Brasher, Nicholas; Walker, Melanie R; Bukh, Jens; Maher, Lisa; Gordon, Tom; Davenport, Miles P; Luciani, Fabio; Drummer, Heidi E; Lloyd, Andrew R; Bull, Rowena A.
Afiliación
  • Underwood AP; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre and Depa
  • Gupta M; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Wu BR; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Eltahla AA; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Boo I; Burnet Institute, Melbourne, VIC, Australia.
  • Wang JJ; Department of Immunology Flinders Medical Centre and Flinders University, SA Pathology Bedford Park, SA, Australia.
  • Agapiou D; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Abayasingam A; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Reynaldi A; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Keoshkerian E; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Zhao Y; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Brasher N; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Walker MR; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Bukh J; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Maher L; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Gordon T; Department of Immunology Flinders Medical Centre and Flinders University, SA Pathology Bedford Park, SA, Australia.
  • Davenport MP; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Luciani F; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Drummer HE; Burnet Institute, Melbourne, VIC, Australia; Department of Microbiology, Monash University, Clayton, VIC, Australia; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Lloyd AR; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
  • Bull RA; School of Biomedical Science, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia; The Kirby Institute, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia. Electronic address: r.bull@unsw.edu.au.
J Hepatol ; 81(3): 415-428, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38604387
ABSTRACT
BACKGROUND &

AIMS:

In individuals highly exposed to HCV, reinfection is common, suggesting that natural development of sterilising immunity is difficult. In those that are reinfected, some will develop a persistent infection, while a small proportion repeatedly clear the virus, suggesting natural protection is possible. The aim of this study was to characterise immune responses associated with rapid natural clearance of HCV reinfection.

METHODS:

Broad neutralising antibodies (nAbs) and Envelope 2 (E2)-specific memory B cell (MBC) responses were examined longitudinally in 15 individuals with varied reinfection outcomes.

RESULTS:

Broad nAb responses were associated with MBC recall, but not with clearance of reinfection. Strong evidence of antigen imprinting was found, and the B-cell receptor repertoire showed a high level of clonality with ongoing somatic hypermutation of many clones over subsequent reinfection events. Single-cell transcriptomic analyses showed that cleared reinfections featured an activated transcriptomic profile in HCV-specific B cells that rapidly expanded upon reinfection.

CONCLUSIONS:

MBC quality, but not necessarily breadth of nAb responses, is important for protection against antigenically diverse variants, which is encouraging for HCV vaccine development. IMPACT AND IMPLICATIONS HCV continues to have a major health burden globally. Limitations in the health infrastructure for diagnosis and treatment, as well as high rates of reinfection, indicate that a vaccine that can protect against chronic HCV infection will greatly complement current efforts to eliminate HCV-related disease. With alternative approaches to testing vaccines, such as controlled human inoculation trials under consideration, we desperately need to identify the correlates of immune protection. In this study, in a small but rare cohort of high-risk injecting drug users who were reinfected multiple times, breadth of neutralisation was not associated with ultimate clearance of the reinfection event. Alternatively, characteristics of the HCV-specific B-cell response associated with B-cell proliferation were. This study indicates that humoral responses are important for protection and suggests that for genetically very diverse viruses, such as HCV, it may be beneficial to look beyond just antibodies as correlates of protection.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepacivirus / Reinfección Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hepacivirus / Reinfección Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article